A 3406
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to increase transparency in prescription drug pricing and reduce costs for consumers in New Jersey. It requires pharmacy benefits managers to disclose details about their pricing methods and how they handle generic drug substitutions. The bill also establishes a commission to identify critical prescription drugs and gather data on their development and pricing, potentially leading to price controls. Finally, it addresses potential price gouging by manufacturers and provides a mechanism for the Attorney General to intervene.
Sponsors
Official sponsors from legislative records.
Primary sponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.